If the newsletter is not displayed properly, please visit our website >>>  


AACR Annual Meeting 2018


EPO will join the AACR Annual Meeting 2018
"Driving Innovative Cancer Science to Patient Care"  in Chicago
between April 14-18.2018.
If you are interested in special approaches or technologies of EPO, or if you want to talk to our CEO Dr. Jens Hoffmann, our expert for hematological PDX models Dr. Antje Siegert, or our marketing representative Dennis France you are kindly invited to meet at our three posters:

Poster #1145 / 2
Humanized immune-PDX mouse models for 10 different tumor entities in translational immuno-oncology research

The poster will be presented in Poster Session "PO.TB01.02 - Translational Therapeutics in Cancer Models 1" on Monday April 16, 2018, 8:00 AM - 12:00 PM, Poster Section 6, Board number 1445 / 2

Poster #1040 / 13
Patient derived xenografts of hematologic malignancies for translational research

The poster will be presented in Poster Session "Session PO.TB01.01 - Advances in the Generation and Analysis of Patient-Derived Xenografts" on Monday April 16, 2018, 8:00 AM - 12:00 PM, Poster Section 2, Board number 1040 / 13

Poster #4093 / 21
Preclinical evaluation of novel treatment strategies in patient-derived xenograft (PDX) models of pancreatic cancer

The poster will be presented in Poster Session "Session PO.TB01.01 - Advances in the Generation and Analysis of Patient-Derived Xenografts" on Tuesday April 17, 2018, 1:00 PM - 5:00 PM, Poster Section 4, Board number 4093 / 21


 The Abstracts of all posters can be read at our homepage
http://www.epo-berlin.com/epo-news.html.

Together with our US partner company NexusPharma we are looking forward to meet you there.

EPO GmbHLogo Nexus Pharma
 


Jens Hoffmann (CEO) 
EPO GmbH Berlin Buch

For more informations visit our Web site: www.epo-berlin.com or contact 
jens.hoffmann@epo-berlin.com

Impress:

EPO Experimental Pharmacology & Oncology Berlin-Buch GmbH
Robert-Rössle-Straße 10, Haus 82
13125 Berlin Germany

Amtsgericht Charlottenburg,Sitz Berlin, HRB 61814


If you no longer wish to receive this newsletter, please click on unsubscibe.

Copyright:EPO GmbH© 2017